Talde, through its fund TCC, F.C.R., enters the shareholding of Tegor Group in order to boost its growth

September 24, 2018
  • Tegor Group manufactures and distributes a wide range of products for Natural Medicine, Aesthetic, Pharmacy and Dietetics sectors.
  • The company’s founders will continue to lead it during this new expansion stage.


Tegor group has permitted entry to Talde in its shareholding through the sale of a majority stake, with a view to boost the growth plan as well as the national and international development of the company in the following years.

Founded in 1993, in Zamudio (Bizkaia), Tegor Group (www.grupotegor.com) manufactures and distributes a wide range of cosmetic products, nutritional and dietary supplements and health products based on medicinal plants; both with their own brand and for third parties. After heavy investments in R&D&I, the company has consolidated its growth in recent years to become a leading innovative company in natural therapies, present in more than 30 countries in Europe, Asia, Africa and America.

The growing tendency for personal care creates expectation for an important development of the markets to which the company is heading, with a significant margin until reaching levels of relative consumption volumes comparable to those in the leading countries of Europe, such as France and Germany. Tegor Group has laboratories equipped with the latest technological advances, which allow it to maintain the highest quality standards, according to the good manufacturing practices (GMP) that the sector demands.

The founders, linked to the shareholding of the company, will continue in its management; supporting the new growing stage of the Group.